Johnson & Johnson beats by $0.06, beats on revenue

Johnson & Johnson (JNJ): Q1 EPS of $1.54 beats by $0.06.

Revenue of $18.11B (+3.5% Y/Y) beats by $110M.

From other sites
Comments (7)
  • tomlos
    , contributor
    Comments (1299) | Send Message
    Very long JNJ!! Great work.
    15 Apr 2014, 07:50 AM Reply Like
  • wam350
    , contributor
    Comments (171) | Send Message
    Good news, long JNJ!
    15 Apr 2014, 07:57 AM Reply Like
  • dstone47
    , contributor
    Comments (14) | Send Message
    Saint Johnson has been great the last 2 years.. Keep going,,, $105 in sight
    Safe Secure and Long ... the PE is higher than others that's ok as long as their is growth. .keep the faith
    15 Apr 2014, 08:41 AM Reply Like
  • JDDurango
    , contributor
    Comments (475) | Send Message
    Congrats JNJ shareholders, been waiting for an entry point but it just goes higher. Haha
    15 Apr 2014, 08:54 AM Reply Like
  • jumpnjoey77
    , contributor
    Comments (1207) | Send Message
    Selling stuff and buying stock back. This thing is going to be a great short.
    15 Apr 2014, 10:02 AM Reply Like
  • Zubunda
    , contributor
    Comments (202) | Send Message
    Strong sales in new biologics/pharmaceutic... would not believe it when seeing how the market treats the biotechs, who probably will show equally strong sales when they report next week...
    15 Apr 2014, 01:28 PM Reply Like
  • Gman72
    , contributor
    Comments (6) | Send Message
    Darn, I'm long 1000 shares but when it dipped below 90 I wrote covered calls at 90. Still hoping it backs off.
    15 Apr 2014, 09:03 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs